Anhui Wanbang Pharmaceutical Technology Co., Ltd. () Stock Recommendation | Score, Valuation, Technicals & Financial Trend

Score

Click here to find our call on this stock

Strong Sell

Sell

Hold

Buy

Strong Buy

MarketsMojo — Loved in India, Now Global

The power of Mojo is now in 29 countries. Explore global equities with the same cutting-edge features you love.Unlock 29 Markets

Comparison

Company

Score

Quality

Valuation

Financial

Technical

Anhui Wanbang Pharmaceutical Technology Co., Ltd.

Why is Anhui Wanbang Pharmaceutical Technology Co., Ltd. ?

High Debt Company with a Debt to Equity ratio (avg) at times

Poor long term growth as Net Sales has grown by an annual rate of 2.99% and Operating profit at -48.52% over the last 5 years
High Debt Company with a Debt to Equity ratio (avg) at times
The company has been able to generate a Return on Equity (avg) of 14.13% signifying low profitability per unit of shareholders funds

With a fall in Net Sales of -22.14%, the company declared Very Negative results in Mar 25

The company has declared negative results for the last 2 consecutive quarters
NET PROFIT(HY) At CNY 27.73 MM has Grown at -46.14%
NET SALES(HY) At CNY 156.06 MM has Grown at -18.11%
RAW MATERIAL COST(Y) Grown by 30.2% (YoY)

Below par performance in long term as well as near term

Along with generating -1.46% returns in the last 1 year, the stock has also underperformed China Shanghai Composite in the last 3 years, 1 year and 3 months

Real-Time Research Report

Verdict Report

How much should you sell?

All quantity irrespective of whether you are making profits or losses

(If sector exposure > 30%, please use optimiser tool to see which are the best stocks to hold in Pharmaceuticals & Biotechnology)

When to re-enter? - We will constantly monitor the company and review our call based on new data

Is Anhui Wanbang Pharmaceutical Technology Co., Ltd. for you?

High Risk, Low Return

Absolute

Risk Adjusted

Volatility

Anhui Wanbang Pharmaceutical Technology Co., Ltd.

-100.0%

0.10

36.77%

China Shanghai Composite

15.19%

1.01

15.10%

Quality

Management Risk

Growth

Capital Structure

Quality grade scale :

Below Average, Average, Good, Excellent

Quality key factors

Factor

Value

Sales Growth (5y)

2.99%

EBIT Growth (5y)

-48.52%

EBIT to Interest (avg)

52.74

Debt to EBITDA (avg)

Net Debt to Equity (avg)

-0.77

Sales to Capital Employed (avg)

0.36

Tax Ratio

1.68%

Dividend Payout Ratio

27.25%

Pledged Shares

Institutional Holding

ROCE (avg)

15.15%

ROE (avg)

14.13%

Valuation

Valuation Scorecard

Valuation grade scale :

Very Risky, Risky, Very Expensive, Expensive, Fair, Attractive, Very Attractive

Valuation Key Factors

Factor

Value

P/E Ratio

Industry P/E

Price to Book Value

0.43

EV to EBIT

-32.70

EV to EBITDA

-14.62

EV to Capital Employed

-1.58

EV to Sales

-1.55

PEG Ratio

Dividend Yield

ROCE (Latest)

Negative Capital Employed

ROE (Latest)

3.41%

Technicals

Technical key factors

Indicator

Weekly

Monthly

MACD

Bearish

RSI

No Signal

Bollinger Bands

Bearish

Moving Averages

Bearish (Daily)

KST

Bearish

Dow Theory

Mildly Bearish

No Trend

OBV

Mildly Bullish

Technical Indicator Scale: Bearish, Mildly Bearish, Sideways, Mildly Bullish, Bullish Turned

Technical Movement

Analyse All Technical Factors

Financial Trend

Financial Trend Scorecard

Financial Trend scale:

Very Negative, Negative, Flat, Positive, Very Positive, Outstanding

3What is working for the Company

OPERATING CASH FLOW(Y)

Highest at CNY 50.57 MM

INVENTORY TURNOVER RATIO(HY)

Highest at 358.33%

-25What is not working for the Company

NET PROFIT(HY)

At CNY 27.73 MM has Grown at -46.14%

NET SALES(HY)

At CNY 156.06 MM has Grown at -18.11%

RAW MATERIAL COST(Y)

Grown by 30.2% (YoY

PRE-TAX PROFIT(Q)

Lowest at CNY 6.26 MM

Here's what is working for Anhui Wanbang Pharmaceutical Technology Co., Ltd.

Operating Cash Flow

Highest at CNY 50.57 MM

in the last three years

MOJO Watch

The company has generated higher cash revenues from business operations

Operating Cash Flows (CNY MM)

Inventory Turnover Ratio

Highest at 358.33%

in the last five Semi-Annual periods

MOJO Watch

Company has been able to sell its inventory faster

Inventory Turnover Ratio

Here's what is not working for Anhui Wanbang Pharmaceutical Technology Co., Ltd.

Net Sales

At CNY 70.68 MM has Fallen at -21.29%

Year on Year (YoY)

MOJO Watch

Near term sales trend is extremely negative

Net Sales (CNY MM)

Pre-Tax Profit

At CNY 6.26 MM has Fallen at -75.43%

Year on Year (YoY)

MOJO Watch

Near term Pre-Tax Profit trend is very negative

Pre-Tax Profit (CNY MM)

Net Profit

At CNY 6.39 MM has Fallen at -72.69%

Year on Year (YoY)

MOJO Watch

Near term Net Profit trend is very negative

Net Profit (CNY MM)

Net Sales

Lowest at CNY 70.68 MM

in the last five periods

MOJO Watch

Near term sales trend is negative

Net Sales (CNY MM)

Pre-Tax Profit

Lowest at CNY 6.26 MM

in the last five periods

MOJO Watch

Near term Pre-Tax Profit trend is negative

Pre-Tax Profit (CNY MM)

Net Profit

Lowest at CNY 6.39 MM

in the last five periods

MOJO Watch

Near term Net Profit trend is negative

Net Profit (CNY MM)

Raw Material Cost

Grown by 30.2% (YoY)

MOJO Watch

The company's ability to pass on the cost of raw materials to customers has deteriorated; this may lead to a fall in profit margin

Raw Material Cost as a percentage of Sales